Search for novel antipsychotic drugs: dopamine forever?

Por Gyertyán, István
Publicado em 2009

Cariprazine, a Dopamine D(3)-Receptor-Preferring Partial Agonist, Blocks Phencyclidine-induced Impairments of Working Memory, Attention Set-Shifting, and Recognition Memory in the...

Por Zimnisky, Ross, Chang, Gloria, Gyertyán, István, Kiss, Béla, Adham, Nika, Schmauss, Claudia
Publicado em 2012

Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Ma...

Por Kostyalik, Diána, Vas, Szilvia, Kátai, Zita, Kitka, Tamás, Gyertyán, István, Bagdy, Gyorgy, Tóthfalusi, László
Publicado no BMC Neurosci (2014)

Cariprazine Exhibits Anxiolytic and Dopamine D(3) Receptor-Dependent Antidepressant Effects in the Chronic Stress Model

Por Duric, Vanja, Banasr, Mounira, Franklin, Tina, Lepack, Ashley, Adham, Nika, Kiss, Béla, Gyertyán, István, Duman, Ronald S.
Publicado no Int J Neuropsychopharmacol (2017)

Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study

Por Kocsis, Pál, Gyertyán, István, Éles, János, Laszy, Judit, Hegedűs, Nikolett, Gajári, Dávid, Deli, Levente, Pozsgay, Zsófia, Dávid, Szabolcs, Tihanyi, Károly
Publicado em 2014

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions

Por Gao, Yonglin, Peterson, Sean, Masri, Bernard, Hougland, M Tyler, Adham, Nika, Gyertyán, Istvan, Kiss, Béla, Caron, Marc G, El-Mallakh, Rif S
Publicado no Pharmacol Res Perspect (2015)

Occupancy of dopamine D(2) and D(3) and serotonin 5-HT(1A) receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emiss...

Por Seneca, Nicholas, Finnema, Sjoerd J., Laszlovszky, István, Kiss, Béla, Horváth, Attila, Pásztor, Gabriella, Kapás, Margó, Gyertyán, István, Farkas, Sándor, Innis, Robert B., Halldin, Christer, Gulyás, Balás
Publicado em 2011